| Ident. | Authors (with country if any) | Title |
|---|
| 000166 (2018) |
Tara M. Babu [États-Unis] ; Ranawaka A P M. Perera ; Joseph T. Wu ; Theresa Fitzgerald [États-Unis] ; Carolyn Nolan [États-Unis] ; Benjamin J. Cowling ; Scott Krauss [États-Unis] ; John J. Treanor [États-Unis] ; Malik Peiris | Population Serologic Immunity to Human and Avian H2N2 Viruses in the United States and Hong Kong for Pandemic Risk Assessment |
| 000220 (2018) |
Guo Luo ; Aditya Ambati ; Ling Lin ; Mélodie Bonvalet ; Markku Partinen [Finlande] ; Xuhuai Ji ; Holden Terry Maecker ; Emmanuel Jean-Marie Mignot | Autoimmunity to hypocretin and molecular mimicry to flu in type 1 narcolepsy |
| 000274 (2017) |
Gerardo Chowell ; Lone Simonsen ; Rodrigo Fuentes ; Jose Flores ; Mark A. Miller ; Cécile Viboud | Severe mortality impact of the 1957 influenza pandemic in Chile |
| 000305 (2017) |
Dennis E. Te Beest [Pays-Bas] ; Erwin De Bruin [Pays-Bas] ; Sandra Imholz [Pays-Bas] ; Marion Koopmans [Pays-Bas] ; Michiel Van Boven [Pays-Bas] | Heterosubtypic cross-reactivity of HA1 antibodies to influenza A, with emphasis on nonhuman subtypes (H5N1, H7N7, H9N2) |
| 000421 (2016) |
April J. Cobos [États-Unis] ; Clinton G. Nelson [États-Unis] ; Megan Jehn [États-Unis] ; Cécile Viboud [États-Unis] ; Gerardo Chowell [États-Unis] | Mortality and transmissibility patterns of the 1957 influenza pandemic in Maricopa County, Arizona |
| 000465 (2016) |
Sergio M. Qui Ones-Parra [Australie] ; E. Bridie Clemens [Australie] ; Zhongfang Wang [Australie] ; Hayley A. Croom [Australie] ; Lukasz Kedzierski [Australie] ; Jodie Mcvernon [Australie] ; Dhanasekaran Vijaykrishna [Singapour] ; Katherine Kedzierska [Australie] | A Role of Influenza Virus Exposure History in Determining Pandemic Susceptibility and CD8+ T Cell Responses |
| 000522 (2015) |
Yulia A. Desheva [Russie] ; Tatiana A. Smolonogina [Russie] ; Svetlana A. Donina [Russie] ; Larisa G. Rudenko [Russie] | Serum strain-specific or cross-reactive neuraminidase inhibiting antibodies against pandemic А/California/07/2009(H1N1) influenza in healthy volunteers |
| 000561 (2015) |
Irina Isakova-Sivak [Russie] ; Marina Stukova [Russie] ; Mariana Erofeeva [Russie] ; Anatoly Naykhin [Russie] ; Svetlana Donina [Russie] ; Galina Petukhova [Russie] ; Victoria Kuznetsova [Russie] ; Irina Kiseleva [Russie] ; Tatiana Smolonogina [Russie] ; Irina Dubrovina [Russie] ; Maria Pisareva [Russie] ; Alexandra Nikiforova [Russie] ; Maureen Power [États-Unis] ; Jorge Flores [États-Unis] ; Larisa Rudenko [Russie] | H2N2 live attenuated influenza vaccine is safe and immunogenic for healthy adult volunteers |
| 000562 (2015) |
Cécile Viboud [États-Unis] ; Lone Simonsen [États-Unis, Danemark] ; Rodrigo Fuentes ; Jose Flores [Chili] ; Mark A. Miller [États-Unis] ; Gerardo Chowell [États-Unis] | Global Mortality Impact of the 1957–1959 Influenza Pandemic |
| 000563 (2015) |
Irina Kiseleva [Russie] ; Irina Dubrovina [Russie] ; Ekaterina Fedorova [Russie] ; Natalie Larionova [Russie] ; Irina Isakova-Sivak [Russie] ; Ekaterina Bazhenova [Russie] ; Maria Pisareva [Russie] ; Victoria Kuznetsova [Russie] ; Jorge Flores [États-Unis] ; Larisa Rudenko [Russie] | Genetic stability of live attenuated vaccines against potentially pandemic influenza viruses. |
| 000691 (2014) |
Gerald Aichinger [Autriche] ; Barbara Grohmann-Izay [Autriche] ; Maikel V. W. Van Der Velden [Autriche] ; Sandor Fritsch [Autriche] ; Manuela Koska [Autriche] ; Daniel Portsmouth [Autriche] ; Mary Kate Hart [États-Unis] ; Wael El-Amin [États-Unis] ; Otfried Kistner [Autriche] ; P. Noel Barrett [Autriche] | Phase I/II Randomized Double-Blind Study of the Safety and Immunogenicity of a Nonadjuvanted Vero Cell Culture-Derived Whole-Virus H9N2 Influenza Vaccine in Healthy Adults |
| 000833 (2013) |
Alexandru Coman [Roumanie] ; Daniel N. Maftei ; Whitney S. Krueger ; Gary L. Heil ; John A. Friary ; Razvan M. Chereches ; Emanuela Sirlincan ; Paul Bria ; Claudiu Dragnea ; Iosif Kasler ; Gregory C. Gray | Serological evidence for avian H9N2 influenza virus infections among Romanian agriculture workers. |
| 000859 (2013) |
Matthew S. Miller [États-Unis] ; Thomas J. Gardner [États-Unis] ; Florian Krammer [États-Unis] ; Lauren C. Aguado [États-Unis] ; Domenico Tortorella [États-Unis] ; Christopher F. Basler [États-Unis] ; Peter Palese [États-Unis] | Neutralizing antibodies against previously-encountered influenza virus strains increase over time: A longitudinal analysis |
| 000A04 (2012) |
Tom Reichert [États-Unis] ; Gerardo Chowell [États-Unis] ; Jonathan A. Mccullers [États-Unis] | The age distribution of mortality due to influenza: pandemic and peri-pandemic |
| 000A27 (2012) |
Filippo Ansaldi [Italie] ; Laura Valle ; Daniela De Florentiis ; Valentina Parodi ; Giuseppe Murdaca ; Bianca Bruzzone ; Paolo Durando ; Maurizio Setti ; Giancarlo Icardi | Phase 4 randomized trial of intradermal low-antigen-content inactivated influenza vaccine versus standard-dose intramuscular vaccine in HIV-1-infected adults. |
| 000A85 (2012) |
Kawsar R. Talaat ; Ruth A. Karron ; Philana H. Liang ; Bridget A. Mcmahon ; Catherine J. Luke ; Bhagvanji Thumar ; Grace L. Chen ; Ji-Young Min ; Elaine W. Lamirande ; Hong Jin ; Kathy L. Coelingh ; George W. Kemble ; Kanta Subbarao | An open‐label phase I trial of a live attenuated H2N2 influenza virus vaccine in healthy adults |
| 000C86 (2011) |
Chao Qiu ; Yang Huang [République populaire de Chine] ; Qian Wang [République populaire de Chine] ; Di Tian ; Wanju Zhang ; Yunwen Hu ; Zhenghong Yuan ; Xiaoyan Zhang ; Jianqing Xu | Boosting Heterosubtypic Neutralization Antibodies in Recipients of 2009 Pandemic H1N1 Influenza Vaccine |
| 000D93 (2010) |
N A Mazurkova ; N N Ryndiuk ; L N Shishkina ; V A Ternovo ; Iu V. Tumanov ; L E Bulychev ; M O Skarnovich ; A S Kabanov ; S G Panchenko ; R P Ale Nikov ; T N Il'Ina ; V I Kuzubov ; S Ia Mel'Nikov ; A N Mironov ; S A Korovkin ; A N Sergeev ; I G Drozdov | [Results of clinical trials on reactogenicity, safety, and immunogenicity of influenza allantoic intranasal live vaccine "Ultragrivac" (type A/H5N2)]. |
| 000E24 (2010) |
Ana Clara Monsalvo [Argentine] ; Juan P. Batalle [Argentine] ; M. Florencia Lopez [Argentine] ; Jens C. Krause [États-Unis] ; Jennifer Klemenc [États-Unis] ; Johanna Zea [Argentine, États-Unis] ; Bernardo Maskin [Argentine] ; Jimena Bugna [Argentine] ; Carlos Rubinstein [Argentine] ; Leandro Aguilar [Argentine] ; Liliana Dalurzo [Argentine] ; Romina Libster [Argentine] ; Vilma Savy [Argentine] ; Elsa Baumeister [Argentine] ; Liliana Aguilar [Argentine] ; Graciela Cabral [Argentine] ; Julia Font [Argentine] ; Liliana Solari [Argentine] ; Kevin P. Weller [États-Unis] ; Joyce Johnson [États-Unis] ; Marcela Echavarria [Argentine] ; Kathryn M. Edwards [États-Unis] ; James D. Chappell [États-Unis] ; James E. Crowe [États-Unis] ; John V. Williams [États-Unis] ; Guillermina A. Melendi [Argentine, États-Unis] ; Fernando P. Polack [Argentine, États-Unis] | Severe pandemic 2009 H1N1 influenza disease due to pathogenic immune complexes |
| 000E74 (2010) |
N. Ikonen [Finlande] ; M. Strengell ; L. Kinnunen ; P. Osterlund ; J. Pirhonen ; M. Broman ; I. Davidkin ; T. Ziegler ; I. Julkunen | High frequency of cross-reacting antibodies against 2009 pandemic influenza A(H1N1) virus among the elderly in Finland. |
| 001062 (2009) |
Ilaria Capua [Italie] ; Anna Kajaste-Rudnitski [Italie] ; Elena Bertoli [Italie] ; Elisa Vicenzi [Italie] | Pandemic Vaccine Preparedness—Have We Left Something Behind? |
| 001132 (2009) |
Kawsar R. Talaat [États-Unis] ; Ruth A. Karron ; Karen A. Callahan ; Catherine J. Luke ; Susan C. Dilorenzo ; Grace L. Chen ; Elaine W. Lamirande ; Hong Jin ; Kathy L. Coelingh ; Brian R. Murphy ; George Kemble ; Kanta Subbarao | A live attenuated H7N3 influenza virus vaccine is well tolerated and immunogenic in a Phase I trial in healthy adults. |
| 001213 (2008) |
Werner Lange | [Pandemic scenarios]. |
| 001243 (2008) |
R J Green [Afrique du Sud] ; C. Feldman ; B. Schoub ; G A Richards ; S A Madhi ; H J Zar ; U. Lalloo ; K. Klugman ; D. Phillips ; N A Cameron ; R R Eggers | Influenza guideline for South Africa--update 2008. |
| 001373 (2007) |
Fred Y. Aoki [Canada] ; Guy Boivin ; Noel Roberts | Influenza virus susceptibility and resistance to oseltamivir. |
| 001382 (2007) |
Michael J. Haber [États-Unis] ; Davis K. Shay [États-Unis] ; Xiaohong M. Davis [États-Unis] ; Rajan Patel [États-Unis] ; Xiaoping Jin [États-Unis] ; Eric Weintraub [États-Unis] ; Evan Orenstein [États-Unis] ; William W. Thompson [États-Unis] | Effectiveness of Interventions to Reduce Contact Rates during a Simulated Influenza Pandemic |
| 001492 (2006) |
Monika Lindemann [Allemagne] ; Oliver Witzke ; Peter Lütkes ; Melanie Fiedler ; Ernst Kreuzfelder ; Thomas Philipp ; Michael Roggendorf ; Hans Grosse-Wilde | ELISpot assay as a sensitive tool to detect cellular immunity following influenza vaccination in kidney transplant recipients. |
| 001513 (2006) |
Suzanne L. Epstein [États-Unis] | Prior H1N1 Influenza Infection and Susceptibility of Cleveland Family Study Participants during the H2N2 Pandemic of 1957: An Experiment of Nature |
| 001516 (2006) |
Edwin D. Kilbourne | Influenza Immunity: New Insights from Old Studies |
| 001587 (2005) |
Rajan Patel [États-Unis] ; Ira M. Longini ; M Elizabeth Halloran | Finding optimal vaccination strategies for pandemic influenza using genetic algorithms. |
| 001660 (2004) |
N. Hehme [Allemagne] ; H. Engelmann ; W. Kuenzel ; E. Neumeier ; R. Saenger | Immunogenicity of a monovalent, aluminum-adjuvanted influenza whole virus vaccine for pandemic use. |
| 001690 (2004) |
Ira M. Longini ; M. Elizabeth Halloran ; Azhar Nizam ; Yang Yang | Containing Pandemic Influenza with Antiviral Agents |
| 001771 (2002) |
N. Hehme [Allemagne] ; H. Engelmann [Allemagne] ; W. Künzel [Allemagne] ; E. Neumeier [Allemagne] ; R. S Nger [Allemagne] | Pandemic preparedness: lessons learnt from H2N2 and H9N2 candidate vaccines |
| 001797 (2001) |
L R Yeolekar [Inde] ; P B Kulkarni ; M S Chadha ; B L Rao | Seroepidemiology of influenza in Pune, India. |
| 001974 (1999) |
| Neuraminidase inhibitors for treatment of influenza A and B infections. |
| 001A43 (1998) |
J. Jameson [États-Unis] ; J. Cruz ; F A Ennis | Human cytotoxic T-lymphocyte repertoire to influenza A viruses. |
| 001A53 (1998) |
Lone Simonsen [Géorgie (pays)] ; Matthew J. Clarke [Géorgie (pays)] ; Lawrence B. Schonberger [Géorgie (pays)] ; Nancy H. Arden [Géorgie (pays)] ; Nancy J. Cox [Géorgie (pays)] ; Keiji Fukuda [Géorgie (pays), États-Unis] | Pandemic versus Epidemic Influenza Mortality: A Pattern of Changing Age Distribution |
| 001B21 (1997) |
K. Matsumoto | [Prevention and control of influenza infection in the elderly in Japan--special emphasis on high risk group patients]. |
| 001B22 (1997) |
K. Hashigucci ; S. Tamura ; T. Kurata ; H. Kamiya ; T. Ishidate | [Efficacy of nasal influenza vaccine combined with Escherichia coli heat-labile enterotoxin B subunit containing a trace amount of the holotoxin in healthy volunteers]. |
| 001C04 (1996) |
S. Chatterjee [Inde] ; K K Mukherjee ; M C Mondal ; M S Chakrabrorty | A study of influenza A virus in the city of Calcutta, India, high lighting the strain prevalence. |
| 001E68 (1993) |
Louis F. Fries [États-Unis] ; Susan B. Dillon [États-Unis] ; James E. K. Hildreth [États-Unis] ; Ruth A. Karron [États-Unis] ; Ann W. Funkhouser [États-Unis] ; Carl J. Friedman [États-Unis] ; Christopher S. Jones [États-Unis] ; Vasantha G. Culleton [États-Unis] ; Mary Lou Clements [États-Unis] | Safety and Immunogenicity of a Recombinant Protein Influenza A Vaccine in Adult Human Volunteers and Protective Efficacy against Wild-Type H1N1 Virus Challenge |
| 001F25 (1992) |
M L Clements [États-Unis] ; E K Subbarao ; L F Fries ; R A Karron ; W T London ; B R Murphy | Use of single-gene reassortant viruses to study the role of avian influenza A virus genes in attenuation of wild-type human influenza A virus for squirrel monkeys and adult human volunteers. |
| 002143 (1989) |
M. H. Pritchard ; Julia Munro | SUCCESSFUL TREATMENT OF. JUVENILE CHRONIC ARTHRITIS WITH A SPECIFIC ANTIVIRAL AGENT |
| 002264 (1988) |
Robert F. Betts [États-Unis] ; R. Gordon Douglas ; Hunien F. Maassab Jr. ; Dan C. Deborde ; Mary Lou Clements [États-Unis] ; Brian R. Murphy | Analysis of virus and host factors in a study of A/Peking/2/79 (H3N2) cold‐adapted vaccine recombinant in which vaccine‐associated illness occurred in normal volunteers |
| 002282 (1987) |
K G Nicholson ; D A Tyrrell ; J S Oxford ; J. Wood ; G C Schild ; C W Potter ; R. Jennings ; R H Michaels ; G. Appleyard | Infectivity and reactogenicity of reassortant cold-adapted influenza A/Korea/1/82 vaccines obtained from the USA and USSR. |
| 002310 (1987) |
R. E. Hope-Simpson [Royaume-Uni] ; D. B. Golubev [Russie] | A new concept of the epidemic process of influenza A virus |
| 002341 (1986) |
M H Snyder ; M L Clements ; R F Betts ; R. Dolin ; A J Buckler-White ; E L Tierney ; B R Murphy | Evaluation of live avian-human reassortant influenza A H3N2 and H1N1 virus vaccines in seronegative adult volunteers. |
| 002352 (1986) |
Tadao Sonoguchi [Japon] ; Mitsuo Sakoh [Japon] ; Nobuharu Kunita [Japon] ; Kiyoaki Satsuta [Japon] ; Hideo Noriki [Japon] ; Hideo Fukumi [Japon] | Reinfection with Influenza A (H2N2, H3N2, and H1N1) Viruses in Soldiers and Students in Japan |
| 002482 (1984) |
G I Karpukhin ; T L Popova ; L S Karpova ; L M Tsybalova ; G M Denisov | [Antigenic anachronism of the influenza A(H2N2) viruses in Leningrad in 1980. I. The epidemiological and serological characteristics of the influenzal infection caused by A/Leningrad/80 (H2N2) viruses]. |
| 002498 (1984) |
N. Yamane [Japon] ; Y. Nakamura [Japon] ; M. Yuki [Japon] ; T. Odagiri [Japon] ; N. Ishida [Japon] | Serological evaluation of an influenza A virus cold-adapted reassortant live vaccine, CR-37 (H1N1), in Japanese adult volunteers |
| 002531 (1984) |
R. E. Hope-Simpson | Age and secular distributions of virus-proven influenza patients in successive epidemics 1961–1976 in Cirencester: Epidemiological significance discussed |
